BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8527290)

  • 1. Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers.
    Ahonen J; Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1995 Sep; 40(3):270-2. PubMed ID: 8527290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
    Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 2006 Nov; 80(5):502-8. PubMed ID: 17112806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin does not increase plasma concentrations of oral midazolam.
    Backman JT; Olkkola KT; Neuvonen PJ
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):356-9. PubMed ID: 7582388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.
    Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
    Varis T; Kivistö KT; Backman JT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.
    Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 2006 Apr; 79(4):362-70. PubMed ID: 16580904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol.
    Lilja JJ; Backman JT; Laitila J; Luurila H; Neuvonen PJ
    Clin Pharmacol Ther; 2003 Mar; 73(3):192-8. PubMed ID: 12621384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam.
    Zimmermann T; Yeates RA; Laufen H; Scharpf F; Leitold M; Wildfeuer A
    Arzneimittelforschung; 1996 Feb; 46(2):213-7. PubMed ID: 8720318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe coadministration of terbinafine and terfenadine: a placebo-controlled crossover study of pharmacokinetic and pharmacodynamic interactions in healthy volunteers.
    Robbins B; Chang CT; Cramer JA; Garreffa S; Hafkin B; Hunt TL; Meligeni J
    Clin Pharmacol Ther; 1996 Mar; 59(3):275-83. PubMed ID: 8653990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.
    Olkkola KT; Ahonen J; Neuvonen PJ
    Anesth Analg; 1996 Mar; 82(3):511-6. PubMed ID: 8623953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.
    Backman JT; Kivistö KT; Olkkola KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Mar; 54(1):53-8. PubMed ID: 9591931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol.
    Saarikoski T; Saari TI; Hagelberg NM; Backman JT; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K
    Eur J Clin Pharmacol; 2015 Mar; 71(3):321-7. PubMed ID: 25560051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of itraconazole on the pharmacokinetics of atenolol.
    Lilja JJ; Backman JT; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):395-8. PubMed ID: 16364056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism.
    Shon JH; Yoon YR; Hong WS; Nguyen PM; Lee SS; Choi YG; Cha IJ; Shin JG
    Clin Pharmacol Ther; 2005 Aug; 78(2):191-201. PubMed ID: 16084853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of effects of terbinafine on single oral dose pharmacokinetics and anticoagulant actions of warfarin in healthy volunteers.
    Guerret M; Francheteau P; Hubert M
    Pharmacotherapy; 1997; 17(4):767-73. PubMed ID: 9250555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ingestion time interval on the interaction between itraconazole and triazolam.
    Neuvonen PJ; Varhe A; Olkkola KT
    Clin Pharmacol Ther; 1996 Sep; 60(3):326-31. PubMed ID: 8841155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of terbinafine on the pharmacokinetics of digoxin in healthy volunteers.
    Tarral A; Francheteau P; Guerret M
    Pharmacotherapy; 1997; 17(4):791-5. PubMed ID: 9250559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid.
    Neuvonen PJ; Jalava KM
    Clin Pharmacol Ther; 1996 Jul; 60(1):54-61. PubMed ID: 8689812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters.
    Yasui-Furukori N; Saito M; Niioka T; Inoue Y; Sato Y; Kaneko S
    Ther Drug Monit; 2007 Feb; 29(1):45-8. PubMed ID: 17304149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.